SRAM
CHRS icon

Spouting Rock Asset Management’s Coherus Oncology CHRS Stock Holding History

Spouting Rock Asset Management’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-14,827
Closed -$238K – 69
2021
Q3 		$238K Sell
14,827
-148
-1% -$2.17K 0.12% 99
2021
Q2 		$207K Sell
14,975
-11,822
-44% -$167K 0.06% 198
2021
Q1 		$392K Buy
+26,797
New +$455K 0.12% 160

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Spouting Rock Asset Management's CHRS Position: Q4 2021 in Review

Spouting Rock Asset Management sold out of Coherus Oncology (CHRS) in Q4 2021, closing a stake of 14,827 shares — an estimated $238K sold.

Spouting Rock Asset Management first reported a position in CHRS in Q1 2021 and held it in 3 quarters. The position peaked at $392K in Q1 2021. 201 funds tracked by Wall St. Rank hold CHRS as of Q4 2021.

  • Spouting Rock Asset Management reported no remaining Coherus Oncology position as of Q4 2021 after selling out during the quarter.
  • Spouting Rock Asset Management sold 14,827 Coherus Oncology shares in Q4 2021, an estimated $238K.
  • Spouting Rock Asset Management first reported a position in Coherus Oncology in Q1 2021 and held it in 3 quarters.
  • Spouting Rock Asset Management's Coherus Oncology position peaked at $392K in Q1 2021.
  • 201 funds tracked by Wall St. Rank held Coherus Oncology as of Q4 2021.

Based on Spouting Rock Asset Management's 13F filing for Q4 2021, filed 10 Feb 2022.